Clinical Trial Update: Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM [Phase 1]

View source ↗

Summary

A Phase I trial evaluating a 5-day regimen of temozolomide plus O6-benzylguanine in patients with recurrent or progressive glioblastoma and gliosarcoma has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: COMPLETED